Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 43, 2012, Pages 17591-17596

  Oakley, Robert H ^a   Revollo, Javier ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; CELL SURFACE RECEPTOR; DEXAMETHASONE; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 1;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRON; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ARRESTINS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84867918890     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1209411109     Document Type: Article

References (26)

1. Wise A, Gearing K, Rees S (2002) Target validation of G-protein coupled receptors. Drug Discov Today 7:235-246. (Pubitemid 34143072)
2. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510.
3. Shenoy SK, Lefkowitz RJ (2011) β-arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32:521-533.
4. Whalen EJ, Rajagopal S, Lefkowitz RJ (2011) Therapeutic potential of β-arrestin- and G protein-biased agonists. Trends Mol Med 17:126-139.
5. Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308:512-517.
6. Luttrell LM, Gesty-Palmer D (2010) Beyond desensitization: Physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305-330.
7. Bychkov ER, Gurevich VV, Joyce JN, Benovic JL, Gurevich EV (2008) Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia. Neurobiol Aging 29:379-396. (Pubitemid 351215580)
8. + T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol 8:817-824.
9. Luan B, et al. (2009) Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457:1146-1149.
10. Archacki SR, et al. (2003) Identification of new genes differentially expressed in coronary artery disease by expression profiling. Physiol Genomics 15:65-74.
11. Liu H, et al. (2011) Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia. Int J Hematol 93:494-501.
12. Oakley RH, Cidlowski JA (2011) Cellular processing of the glucocorticoid receptor gene and protein: New mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286:3177-3184.
13. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353:1711-1723.
14. Hershko DD, Robb BW, Wray CJ, Luo GJ, Hasselgren PO (2004) Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-kappaB in cultured caco-2 cells. J Cell Biochem 91:951-961.
15. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR (2007) Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:e94.
16. Wang JC, et al. (2004) Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA 101:15603-15608.
17. Surjit M, et al. (2011) Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:224-241.
18. Reddy TE, et al. (2009) Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 19:2163-2171.
19. Chen CH, Paing MM, Trejo J (2004) Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation. J Biol Chem 279:10020-10031. (Pubitemid 38372605)
20. Kuo FT, Lu TL, Fu HW (2006) Opposing effects of beta-arrestin1 and beta-arrestin2 on activation and degradation of Src induced by protease-activated receptor 1. Cell Signal 18:1914-1923.
21. Paing MM, Stutts AB, Kohout TA, Lefkowitz RJ, Trejo J (2002) Beta-arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J Biol Chem 277:1292-1300. (Pubitemid 34968882)
22. Vergnolle N (2009) Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther 123:292-309.
23. Barnes PJ (2011) Biochemical basis of asthma therapy. J Biol Chem 286:32899-32905.
24. Schmidt M, Michel MC (2011) How can 1 + 1 = 3? β2-adrenergic and glucocorticoid receptor agonist synergism in obstructive airway diseases. Mol Pharmacol 80:955-958.
25. Walker JK, et al. (2003) Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 112:566-574. (Pubitemid 38056341)
26. Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: Biasing seven-transmembrane receptors. Nat Rev Drug Discov 9:373-386.